Pressemitteilung BoxID: 580466 (axanta AG)
  • axanta AG
  • Huntestraße 12
  • 26135 Oldenburg
  • Ansprechpartner
  • Dietmar Müller
  • +49 (173) 6733538

Successful asset deal by axanta AG: Alhopharm sells rights for two pharmaceuticals

(PresseBox) (Oldenburg, ) Alphopharm Arzneimittel GmbH, located in Aßlar in the Middle Hesse region of Germany, divested and transferred trademarks and market approvals for two of its pharmaceutical products to Dr. Fischer Gesundheitsprodukte GmbH based in Gräfelfing, near Munich. The successful asset deal took place in February 2013 and was assisted by axanta AG.

Formed in 2006, axanta AG is one of Germany's leading independent M&A consultancies in the area of business takeovers and sales, succession plans and corporate investments in small and medium-sized companies.

Alhopharm Arzneimittel GmbH was founded in 1969 and focuses on the sales and marketing of phytopharmaceutical products and homeopathic remedies. The enterprise is the proprietor of approvals and registrations of several brands used in various therapeutic areas: food intolerance, rheumatic complaints, cardio-vascular problems, motion sickness, respiratory infections, nervous disorders, etc. The approvals carry on in their original form. The brands are nurtured and well-defended.

The development potential of this company is substantial, since thus far the sales and marketing has only taken place locally. Considerable sales potential could be generated through nationwide marketing. The owners, Mrs. Margarete Heidl and Dr. Reiner Heidl, wanted to divest their company due to reasons of age; and they engaged axanta AG to sell the enterprise.

In the course of the sales process, it was determined that a sale of the entire company did not meet the needs and requirements of the market.

The prospective buyers' market presence is in accordance with their own specific therapeutic areas, and they are searching for supplemental preparations. Therefore, the proprietors decided to sell their individual preparations.

"The sale of smaller and very small companies repeatedly creates challenges for us, since the entire enterprise is solely centered around the proprietor. If he is no longer on board and there is no adequate representative, as in the above mentioned case, many prospective buyers are scared off. In these cases creative solutions are needed. This includes the sale of assets instead of the sale of a company's shares", explains Udo Goetz, CEO of axanta AG.

axanta AG

axanta AG, founded in 2006, is one of the market leaders amongst consultancies for buying and selling companies, succession plans and corporate investments in Germany. Public funding counseling is also included in the firm's service spectrum, which focuses specifically on small and medium-sized companies. In corporate investments, axanta AG acts as an intermediary for both share options where the holder is passive or active. In addition to the headquarters in Oldenburg, the company has offices in Berlin, Munich, Düsseldorf and Frankfurt am Main. Hence, axanta AG is active nationwide and brings regional market knowledge to all major areas of the economy.

The mainstays of axanta's corporate philosophy include a maximum of discretion, well-documented independent corporate valuations and, above all, the high professional and social competence of its workforce.

Extensive documentation and individual guidance are crucial elements of the service package offered. Supporting and advising the client spans the whole process right up to the point of sale or purchase and beyond. Recently axanta AG added an extensive public funding counseling service for entrepreneurs.

learn more at www.axanta-fö axanta AG was one of the first companies to be awarded the ISO Certificate 9001 from the TÜV Nord for its well-structured processes.
learn more at

Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an